Skip to main content
Clinical Trials/NCT03344679
NCT03344679
Completed
Not Applicable

A Comparative Study of Ultrasound Guided PECS Block Using Bupivacaine Adenosine Versus Bupivacaine Magnesium Sulphate: A Randomised Controlled Trial.

Menoufia University0 sites90 target enrollmentFebruary 1, 2015

Overview

Phase
Not Applicable
Intervention
Bupivacaine 0.25%
Conditions
Breast Surgery
Sponsor
Menoufia University
Enrollment
90
Primary Endpoint
Visual analogue scale (VAS)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Pectoral nerve block (PECS) has been used for post-operative pain relief in patients undergoing breast surgery. It has been shown that adenosine has an effect on pain modulation. Magnesium sulphate has been used as an adjuvant to local anaesthetics in many nerve block techniques. We hypothesised that adenosine may affect the PECS block quality. We aimed to compare the effect of adding adenosine to the local anaesthetic and compare its effect to magnesium sulphate when used for PECS block.

Detailed Description

The present study was conducted on 90 adult patients aged between 20 and 65 years old. Patients scheduled for modified radical mastectomy with axillary clearance surgery American Society of Anaesthetist (ASA) classes I, II, and III patients were included in the study. Patients were randomly allocated into on of three groups according to the adjuvant used with the local anaesthetic, 30 patients in each group using a computerised program. All patients received PECS block. Group (C) received PECS block with 0.25% bupivacaine (control group), group (A) bupivacaine with added adenosine, and group (M) bupivacaine with added magnesium sulphate. The local anaesthetic syringes were prepared by an independent anaesthetist. The researchers and the patients were blinded to the local anaesthetic adjuvant in the syringes. All patients received 30 ml local anaesthetic for PECS. The 30 ml local anaesthetic used for each patient contained bupivacaine hydrochloride 0.25%, bupivacaine hydrochloride 0.25% and 12 mg adenosine, and bupivacaine hydrochloride 0.25% and 500 mg magnesium sulphate for groups C, A, and M respectively. Patients' demographic data were collected including age, BMI, ASA, and duration of surgery. In the post- anesthetic care unit (PACU) the visual analogue score (VAS) was assessed on arrival and then every 15 minutes. The duration and the quality of the block was recorded.

Registry
clinicaltrials.gov
Start Date
February 1, 2015
End Date
July 22, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr Ezzeldin Ibrahim

Assistant Professor in anaesthesia, intensive care, and pain medicine.

Menoufia University

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled for modified radical mastectomy with axillary clearance surgery ASA classes I, II, and III patients were included in the study

Exclusion Criteria

  • contraindications for regional anesthesia such as coagulopathy, local infection and fungating breast cancer, 2) history of allergy to the medications used in the study, 3) patient with history of drug abuse, 4) previous breast surgery except for diagnostic biopsies, 5) history of treatment for a chronic pain condition, 6) psychiatric disorder.

Arms & Interventions

Control group

Bupivacaine 0.25% for pectoral nerve block.

Intervention: Bupivacaine 0.25%

Adenosine

Bupivacaine 0.25% with added Adenosine 12mg for pectoral nerve block.

Intervention: Bupivacaine 0.25%

Adenosine

Bupivacaine 0.25% with added Adenosine 12mg for pectoral nerve block.

Intervention: Adenosine 12mg

Magnesium sulphate

Bupivacaine 0.25% with Magnesium sulphate 500 mg for pectoral nerve block.

Intervention: Bupivacaine 0.25%

Magnesium sulphate

Bupivacaine 0.25% with Magnesium sulphate 500 mg for pectoral nerve block.

Intervention: Magnesium Sulphate 500 mg

Outcomes

Primary Outcomes

Visual analogue scale (VAS)

Time Frame: First 24 hours after surgery

Visual analogue scale is a scale from 1 to 10 where 1 is no pain and 10 is the worst pain the patient experienced.

Secondary Outcomes

  • PECS block duration.(First 24 hours after surgery)
  • Mean arterial blood pressure (mmHg)(Intra-operative (from induction of anaesthesia until the patient is awake))
  • Heart rate (beat/minute)(Intra-operative(from induction of anaesthesia until the patient is awake))
  • Analgesic requirement(First 24 hours after surgery)

Similar Trials